Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 4:13:1179544120946743.
doi: 10.1177/1179544120946743. eCollection 2020.

Expert Opinion on the Extensive Use of Prescription Crystalline Glucosamine Sulfate in the Multimodal Treatment of Osteoarthritis in Ukraine, Kazakhstan, Uzbekistan, and Armenia

Andriy M Gnylorybov  1 , Semen K Ter-Vartanian  2 , Irina Y Golovach  3 , Oleg E Vyrva  4 , Oleksandr A Burianov  5 , Gulnara S Yesirkepova  6 , Murodjon E Irismetov  7 , Mashkhura Z Rizamuhamedova  8 , Valentina S Vardanyan  9 , Knarik V Ginosyan  10
Affiliations

Expert Opinion on the Extensive Use of Prescription Crystalline Glucosamine Sulfate in the Multimodal Treatment of Osteoarthritis in Ukraine, Kazakhstan, Uzbekistan, and Armenia

Andriy M Gnylorybov et al. Clin Med Insights Arthritis Musculoskelet Disord. .

Abstract

Objective: The present work was led by a multidisciplinary panel of experts and proposes an extensive review on the use of prescription crystalline glucosamine sulfate (pCGS) in the multimodal treatment of osteoarthritis (OA) applicable in Ukraine and other Commonwealth of Independent States (CIS) countries.

Methods: A panel of rheumatologists, orthopedic surgeons, and field experts from Ukraine and CIS regions discussed the management of OA. Literature was systematically searched using Medline, EMBASE, CIHNAL, and Cochrane Library databases. The 2-day meeting critically reviewed the available literature, treatment algorithms, pharmacoeconomic aspects, and real-world instances to form a multimodal approach based both on real-life clinical practice and systematic literature research for the management of OA in Ukraine and CIS countries.

Expert opinion: pCGS plays a pivotal role in the stepwise approach to OA treatment. If it is necessary (step 1), the combined use of pCGS with paracetamol and topical nonsteroidal anti-inflammatory drugs (NSAIDs) has been recommended. If symptoms persist, oral NSAIDs and intra-articular (IA) hyaluronic acid or corticosteroids are added to the therapy (step 2) of pCGS in the patients. In case of insufficient relief and severe OA (step 3), pCGS along with oral NSAIDs, IA corticosteroids, and duloxetine have been recommended. Patient stratification with regular monitoring and careful alterations in treatment were advocated.

Conclusions: This expert opinion article recommends a modified approach to the existing guidelines incorporating pCGS in treatment modality of OA in Ukraine and CIS countries. Extensive use of pCGS targets early symptomatic relief in OA while limiting the adverse effects due to long-term use of analgesics and NSAIDs.

Keywords: Commonwealth of Independent States (CIS) countries; Osteoarthritis; SYSADOAs; Ukraine; crystalline glucosamine sulfate; expert opinion.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Stepwise treatment recommendation for management of OA. CS indicates chondroitin sulfate; IA, intra-articular; IM, intra-muscular; NSAIDs, nonsteroidal anti-inflammatory drugs; OA, osteoarthritis; pCGS, patented crystalline glucosamine sulfate; PO, per oral; SYSADOA, Symptomatic Slow Acting Drugs for Osteoarthritis.
Figure 2.
Figure 2.
Molecular structure of stable crystalline glucosamine sulfate.
See this image and copyright information in PMC

References

    1. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000;59:936-944. doi:10.1136/ard.59.12.936. - DOI - PMC - PubMed
    1. Wallace IJ, Worthington S, Felson DT, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci. 2017;114:9332-9336. doi:10.1073/pnas.1703856114. - DOI - PMC - PubMed
    1. Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1211-1259. doi:10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
    1. Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford). 2014;53:937-947. doi:10.1093/rheumatology/ket463. - DOI - PubMed
    1. Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45:S3-S11. doi:10.1016/j.semarthrit.2015.11.010. - DOI - PubMed

LinkOut - more resources